Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA35 for Pain Treatment
NCT05756595Completed
- Sponsor
- Dove Medical Press
- Start
- Jul 2020
- Primary completion
- Dec 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of ha35 in herpes zoster (HZ), shoulder pain, Cervicalgia and 1 more, sponsored by Dove Medical Press. Primary endpoint: Pain scores of all shoulder, neck, back, temporal and herpes zoster pain at 3 hours. Started Jul 2020; status: completed.
02
Drugs
ha35
03
Conditions
herpes zoster (HZ)shoulder painCervicalgiaback pain
Beyond the preview
Go deeper on NCT05756595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05756595.